NASDAQ:SILK - Silk Road Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$44.84 -0.38 (-0.84 %)
(As of 05/24/2019 04:00 PM ET)
Previous Close$45.22
Today's Range$44.80 - $46.17
52-Week Range$30.87 - $49.55
Volume1,031 shs
Average Volume223,138 shs
Market Capitalization$1.38 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.

Receive SILK News and Ratings via Email

Sign-up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SILK
CUSIPN/A
CIKN/A
Phone408-720-9002

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees176
Market Cap$1.38 billion
Next Earnings Date8/14/2019 (Estimated)
OptionableNot Optionable

Silk Road Medical (NASDAQ:SILK) Frequently Asked Questions

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

When is Silk Road Medical's next earnings date?

Silk Road Medical is scheduled to release their next quarterly earnings announcement on Wednesday, August 14th 2019. View Earnings Estimates for Silk Road Medical.

What price target have analysts set for SILK?

4 Wall Street analysts have issued 1-year target prices for Silk Road Medical's shares. Their predictions range from $40.01 to $45.00. On average, they expect Silk Road Medical's stock price to reach $43.0025 in the next year. This suggests that the stock has a possible downside of 4.1%. View Analyst Price Targets for Silk Road Medical.

What is the consensus analysts' recommendation for Silk Road Medical?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Silk Road Medical.

Has Silk Road Medical been receiving favorable news coverage?

News coverage about SILK stock has been trending negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Silk Road Medical earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next few days.

Who are some of Silk Road Medical's key competitors?

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Splunk (SPLK), DexCom (DXCM), salesforce.com (CRM), Paypal (PYPL), Workday (WDAY), Canopy Growth (CGC), ServiceNow (NOW), Twilio (TWLO), BioTelemetry (BEAT) and Coupa Software (COUP).

Who are Silk Road Medical's key executives?

Silk Road Medical's management team includes the folowing people:
  • Ms. Erica J. Rogers, Chief Exec. Officer, Pres & Director (Age 55)
  • Mr. Lucas W. Buchanan, Chief Financial Officer (Age 41)
  • Mr. Robert A. Nicholas, VP of Operations & Engineering (Age 56)
  • Mr. Andrew S. Davis, Exec. VP of Global Sales & Marketing (Age 50)
  • Ms. Alison Highlander, VP of HR

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

When did Silk Road Medical's quiet period expire?

Silk Road Medical's quiet period expired on Tuesday, May 14th. Silk Road Medical had issued 6,000,000 shares in its public offering on April 4th. The total size of the offering was $120,000,000 based on an initial share price of $20.00. During Silk Road Medical's quiet period, insiders and underwriters that worked on the IPO were prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Silk Road Medical?

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $44.84.

How big of a company is Silk Road Medical?

Silk Road Medical has a market capitalization of $1.38 billion. Silk Road Medical employs 176 workers across the globe.

What is Silk Road Medical's official website?

The official website for Silk Road Medical is http://silkroadmed.com/.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected]


MarketBeat Community Rating for Silk Road Medical (NASDAQ SILK)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  4 (Vote Outperform)
Underperform Votes:  2 (Vote Underperform)
Total Votes:  6
MarketBeat's community ratings are surveys of what our community members think about Silk Road Medical and other stocks. Vote "Outperform" if you believe SILK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SILK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel